JP2009514936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009514936A5 JP2009514936A5 JP2008539493A JP2008539493A JP2009514936A5 JP 2009514936 A5 JP2009514936 A5 JP 2009514936A5 JP 2008539493 A JP2008539493 A JP 2008539493A JP 2008539493 A JP2008539493 A JP 2008539493A JP 2009514936 A5 JP2009514936 A5 JP 2009514936A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrrolo
- dihydro
- quinoline
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 33
- 208000015181 infectious disease Diseases 0.000 claims description 24
- 239000013066 combination product Substances 0.000 claims description 11
- 229940127555 combination product Drugs 0.000 claims description 11
- 206010034674 peritonitis Diseases 0.000 claims description 11
- 208000002474 Tinea Diseases 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 201000010099 disease Diseases 0.000 claims description 8
- 241000893966 Trichophyton verrucosum Species 0.000 claims description 7
- 206010007882 Cellulitis Diseases 0.000 claims description 6
- 201000000297 Erysipelas Diseases 0.000 claims description 6
- 208000005141 Otitis Diseases 0.000 claims description 6
- 206010013023 diphtheria Diseases 0.000 claims description 6
- 208000019258 ear infection Diseases 0.000 claims description 6
- 208000004396 mastitis Diseases 0.000 claims description 6
- 201000008827 tuberculosis Diseases 0.000 claims description 6
- 208000000143 urethritis Diseases 0.000 claims description 6
- 208000010201 Exanthema Diseases 0.000 claims description 5
- 206010018691 Granuloma Diseases 0.000 claims description 5
- 206010037660 Pyrexia Diseases 0.000 claims description 5
- 201000005884 exanthem Diseases 0.000 claims description 5
- 206010037844 rash Diseases 0.000 claims description 5
- 201000009906 Meningitis Diseases 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 208000010195 Onychomycosis Diseases 0.000 claims description 4
- 241001420836 Ophthalmitis Species 0.000 claims description 4
- 208000037386 Typhoid Diseases 0.000 claims description 4
- 208000028104 epidemic louse-borne typhus Diseases 0.000 claims description 4
- 208000010403 panophthalmitis Diseases 0.000 claims description 4
- 201000005882 tinea unguium Diseases 0.000 claims description 4
- 201000008297 typhoid fever Diseases 0.000 claims description 4
- 206010060921 Abdominal abscess Diseases 0.000 claims description 3
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 3
- 206010003011 Appendicitis Diseases 0.000 claims description 3
- 206010053555 Arthritis bacterial Diseases 0.000 claims description 3
- 201000002909 Aspergillosis Diseases 0.000 claims description 3
- 208000036641 Aspergillus infections Diseases 0.000 claims description 3
- 241000193738 Bacillus anthracis Species 0.000 claims description 3
- 208000003508 Botulism Diseases 0.000 claims description 3
- 206010006500 Brucellosis Diseases 0.000 claims description 3
- 241000222122 Candida albicans Species 0.000 claims description 3
- 206010007134 Candida infections Diseases 0.000 claims description 3
- 201000007336 Cryptococcosis Diseases 0.000 claims description 3
- 241000221204 Cryptococcus neoformans Species 0.000 claims description 3
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 3
- 206010064687 Device related infection Diseases 0.000 claims description 3
- 206010014561 Emphysema Diseases 0.000 claims description 3
- 206010014568 Empyema Diseases 0.000 claims description 3
- 208000004232 Enteritis Diseases 0.000 claims description 3
- 208000001860 Eye Infections Diseases 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 241000207202 Gardnerella Species 0.000 claims description 3
- 201000000628 Gas Gangrene Diseases 0.000 claims description 3
- 206010017964 Gastrointestinal infection Diseases 0.000 claims description 3
- 206010048461 Genital infection Diseases 0.000 claims description 3
- 206010018612 Gonorrhoea Diseases 0.000 claims description 3
- 201000002563 Histoplasmosis Diseases 0.000 claims description 3
- 208000004023 Legionellosis Diseases 0.000 claims description 3
- 206010024229 Leprosy Diseases 0.000 claims description 3
- 206010024238 Leptospirosis Diseases 0.000 claims description 3
- 206010024641 Listeriosis Diseases 0.000 claims description 3
- 206010024652 Liver abscess Diseases 0.000 claims description 3
- 208000016604 Lyme disease Diseases 0.000 claims description 3
- 206010029240 Neuritis Diseases 0.000 claims description 3
- 206010029443 Nocardia Infections Diseases 0.000 claims description 3
- 206010029444 Nocardiosis Diseases 0.000 claims description 3
- 206010048685 Oral infection Diseases 0.000 claims description 3
- 206010031252 Osteomyelitis Diseases 0.000 claims description 3
- 206010033645 Pancreatitis Diseases 0.000 claims description 3
- 208000004842 Pinta Diseases 0.000 claims description 3
- 206010035148 Plague Diseases 0.000 claims description 3
- 208000002151 Pleural effusion Diseases 0.000 claims description 3
- 206010035664 Pneumonia Diseases 0.000 claims description 3
- 208000031482 Prosthesis-Related Infections Diseases 0.000 claims description 3
- 208000006311 Pyoderma Diseases 0.000 claims description 3
- 206010037688 Q fever Diseases 0.000 claims description 3
- 206010039438 Salmonella Infections Diseases 0.000 claims description 3
- 206010040047 Sepsis Diseases 0.000 claims description 3
- 206010040070 Septic Shock Diseases 0.000 claims description 3
- 208000031650 Surgical Wound Infection Diseases 0.000 claims description 3
- 241000130764 Tinea Species 0.000 claims description 3
- 206010044248 Toxic shock syndrome Diseases 0.000 claims description 3
- 231100000650 Toxic shock syndrome Toxicity 0.000 claims description 3
- 206010046914 Vaginal infection Diseases 0.000 claims description 3
- 201000008100 Vaginitis Diseases 0.000 claims description 3
- 206010052428 Wound Diseases 0.000 claims description 3
- 206010048038 Wound infection Diseases 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 claims description 3
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 206010061418 Zygomycosis Diseases 0.000 claims description 3
- 206010000269 abscess Diseases 0.000 claims description 3
- 206010000496 acne Diseases 0.000 claims description 3
- 201000007691 actinomycosis Diseases 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 3
- 208000025255 bacterial arthritis Diseases 0.000 claims description 3
- 201000007032 bacterial conjunctivitis Diseases 0.000 claims description 3
- 206010006451 bronchitis Diseases 0.000 claims description 3
- 201000003984 candidiasis Diseases 0.000 claims description 3
- 201000001352 cholecystitis Diseases 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 201000003107 cutaneous diphtheria Diseases 0.000 claims description 3
- 201000003146 cystitis Diseases 0.000 claims description 3
- 208000002925 dental caries Diseases 0.000 claims description 3
- 206010062952 diffuse panbronchiolitis Diseases 0.000 claims description 3
- 208000019836 digestive system infectious disease Diseases 0.000 claims description 3
- 208000001848 dysentery Diseases 0.000 claims description 3
- 206010014665 endocarditis Diseases 0.000 claims description 3
- 210000000918 epididymis Anatomy 0.000 claims description 3
- 201000010063 epididymitis Diseases 0.000 claims description 3
- 208000001606 epiglottitis Diseases 0.000 claims description 3
- 208000011323 eye infectious disease Diseases 0.000 claims description 3
- 210000000609 ganglia Anatomy 0.000 claims description 3
- 208000007565 gingivitis Diseases 0.000 claims description 3
- 208000001786 gonorrhea Diseases 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 3
- 231100000283 hepatitis Toxicity 0.000 claims description 3
- 201000001371 inclusion conjunctivitis Diseases 0.000 claims description 3
- 230000002458 infectious effect Effects 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 claims description 3
- 206010023332 keratitis Diseases 0.000 claims description 3
- 210000002751 lymph Anatomy 0.000 claims description 3
- 201000007524 mucormycosis Diseases 0.000 claims description 3
- 208000011079 pinta disease Diseases 0.000 claims description 3
- 230000002980 postoperative effect Effects 0.000 claims description 3
- 201000007094 prostatitis Diseases 0.000 claims description 3
- 208000011354 prosthesis-related infectious disease Diseases 0.000 claims description 3
- 206010039447 salmonellosis Diseases 0.000 claims description 3
- 201000009890 sinusitis Diseases 0.000 claims description 3
- 206010040872 skin infection Diseases 0.000 claims description 3
- 208000006379 syphilis Diseases 0.000 claims description 3
- 230000009885 systemic effect Effects 0.000 claims description 3
- 206010044325 trachoma Diseases 0.000 claims description 3
- 206010061393 typhus Diseases 0.000 claims description 3
- 208000011479 upper respiratory tract disease Diseases 0.000 claims description 3
- 208000006448 Buruli Ulcer Diseases 0.000 claims description 2
- 208000023081 Buruli ulcer disease Diseases 0.000 claims description 2
- 208000004145 Endometritis Diseases 0.000 claims description 2
- 206010066289 Mycobacterium ulcerans infection Diseases 0.000 claims description 2
- 206010029216 Nervousness Diseases 0.000 claims description 2
- 206010037596 Pyelonephritis Diseases 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 206010044008 tonsillitis Diseases 0.000 claims description 2
- -1 1-methylbenzimidazol-2-yl Chemical group 0.000 claims 43
- 125000000217 alkyl group Chemical group 0.000 claims 35
- 125000005843 halogen group Chemical group 0.000 claims 31
- 125000001424 substituent group Chemical group 0.000 claims 30
- 125000003545 alkoxy group Chemical group 0.000 claims 22
- 244000005700 microbiome Species 0.000 claims 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 12
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 9
- 230000000813 microbial effect Effects 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 6
- 241000894006 Bacteria Species 0.000 claims 6
- 206010017533 Fungal infection Diseases 0.000 claims 6
- 241000233866 Fungi Species 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 5
- 239000003242 anti bacterial agent Substances 0.000 claims 5
- 239000003085 diluting agent Substances 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 208000031888 Mycoses Diseases 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 3
- 229940121375 antifungal agent Drugs 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- XCZMUTGHJBFKPM-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CCC=4C=CC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 XCZMUTGHJBFKPM-UHFFFAOYSA-N 0.000 claims 2
- OERPTDFVMBVZJG-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(3-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C(C=1)=CC=CC=1OC1=CC=CC=C1 OERPTDFVMBVZJG-UHFFFAOYSA-N 0.000 claims 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims 2
- 206010009657 Clostridium difficile colitis Diseases 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 241000282324 Felis Species 0.000 claims 2
- 241000220223 Fragaria Species 0.000 claims 2
- DGMPVYSXXIOGJY-UHFFFAOYSA-N Fusaric acid Chemical compound CCCCC1=CC=C(C(O)=O)N=C1 DGMPVYSXXIOGJY-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims 2
- 241000219470 Mirabilis Species 0.000 claims 2
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 claims 2
- 206010037128 Pseudomembranous colitis Diseases 0.000 claims 2
- 206010037151 Psittacosis Diseases 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 206010041925 Staphylococcal infections Diseases 0.000 claims 2
- 108010034396 Streptogramins Proteins 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 230000000843 anti-fungal effect Effects 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 208000024386 fungal infectious disease Diseases 0.000 claims 2
- 239000000417 fungicide Substances 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims 2
- 229960004011 methenamine Drugs 0.000 claims 2
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 201000000901 ornithosis Diseases 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000006748 scratching Methods 0.000 claims 2
- 230000002393 scratching effect Effects 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims 2
- 229960001082 trimethoprim Drugs 0.000 claims 2
- YKJYKKNCCRKFSL-RDBSUJKOSA-N (-)-anisomycin Chemical compound C1=CC(OC)=CC=C1C[C@@H]1[C@H](OC(C)=O)[C@@H](O)CN1 YKJYKKNCCRKFSL-RDBSUJKOSA-N 0.000 claims 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims 1
- XKTFQMCPGMTBMD-ZDBABOMLSA-N (2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-[2-[2-[(2s,3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]hepta-2,6-dienamide Chemical compound NC(=O)/C=C(\OC)[C@H](C)[C@@H](OC)\C=C\C1=CSC(C=2N=C(SC=2)[C@@H](C)\C=C\C=C\C(C)C)=N1 XKTFQMCPGMTBMD-ZDBABOMLSA-N 0.000 claims 1
- KOFBVFFPLADGGO-DUSUDKPKSA-N (3r,4s,5r,6r)-6-[(1r,2r)-1-amino-2-hydroxypropyl]oxane-2,3,4,5-tetrol Chemical compound C[C@@H](O)[C@@H](N)[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O KOFBVFFPLADGGO-DUSUDKPKSA-N 0.000 claims 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 1
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 claims 1
- VXYKUIAUNFUESH-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-ylmethyl)-6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2OCOC2=CC(CN2CCC=3C(C)=NC4=C(OC)C=C(C=C4C=32)OC)=C1 VXYKUIAUNFUESH-UHFFFAOYSA-N 0.000 claims 1
- DVWXIUFCHHVNDT-UHFFFAOYSA-N 1-(1-benzylpiperidin-4-yl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C4CCN(CC=5C=CC=CC=5)CC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 DVWXIUFCHHVNDT-UHFFFAOYSA-N 0.000 claims 1
- QGXUAOBBZQTJPC-UHFFFAOYSA-N 1-(1-benzylpyrrolidin-3-yl)-8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C(C1)CCN1CC1=CC=CC=C1 QGXUAOBBZQTJPC-UHFFFAOYSA-N 0.000 claims 1
- FZNPGWDLTIHOCL-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CC4OC5=CC=CC=C5OC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 FZNPGWDLTIHOCL-UHFFFAOYSA-N 0.000 claims 1
- OEHBVJMUGBVLBC-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1OC2=CC=CC=C2OC1CN1CCC2=C1C1=CC(OC)=CC=C1N=C2C OEHBVJMUGBVLBC-UHFFFAOYSA-N 0.000 claims 1
- WODUWSOPQKIYEZ-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-1-yl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C4C5=CC=CC=C5CC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 WODUWSOPQKIYEZ-UHFFFAOYSA-N 0.000 claims 1
- KCGNRXDVBCFUOZ-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-1-yl)-6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC2=CC=CC=C2C1N1CCC2=C1C1=CC(OC)=CC(OC)=C1N=C2C KCGNRXDVBCFUOZ-UHFFFAOYSA-N 0.000 claims 1
- JVTNCEXFLROSJQ-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-2-yl)-4-methyl-6-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC=C2C=3N(C4CC5=CC=CC=C5C4)CCC=3C(C)=NC2=C1OC1=CC=CC=C1 JVTNCEXFLROSJQ-UHFFFAOYSA-N 0.000 claims 1
- RGYMMMXHXLDZQA-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-2-yl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C4CC5=CC=CC=C5C4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 RGYMMMXHXLDZQA-UHFFFAOYSA-N 0.000 claims 1
- CCOOYLVRANBZSZ-UHFFFAOYSA-N 1-(3-methoxypropyl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound COCCCN1CCC(C(=NC2=CC=3)C)=C1C2=CC=3OC1=CC=CC=C1 CCOOYLVRANBZSZ-UHFFFAOYSA-N 0.000 claims 1
- AZDOESBFPVLBNQ-UHFFFAOYSA-N 1-(4-methoxyphenyl)-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(OC)=CC=C1N1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 AZDOESBFPVLBNQ-UHFFFAOYSA-N 0.000 claims 1
- WODUWSOPQKIYEZ-AREMUKBSSA-N 1-[(1r)-2,3-dihydro-1h-inden-1-yl]-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N([C@H]4C5=CC=CC=C5CC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 WODUWSOPQKIYEZ-AREMUKBSSA-N 0.000 claims 1
- WODUWSOPQKIYEZ-SANMLTNESA-N 1-[(1s)-2,3-dihydro-1h-inden-1-yl]-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N([C@@H]4C5=CC=CC=C5CC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 WODUWSOPQKIYEZ-SANMLTNESA-N 0.000 claims 1
- NPAJRZSZPGYVKP-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CCC=4C=CC(Cl)=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 NPAJRZSZPGYVKP-UHFFFAOYSA-N 0.000 claims 1
- CWJMKVLYTPYIPW-UHFFFAOYSA-N 1-[2-(4-methoxyphenyl)ethyl]-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(OC)=CC=C1CCN1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 CWJMKVLYTPYIPW-UHFFFAOYSA-N 0.000 claims 1
- DDKUAZFTMXXZIS-UHFFFAOYSA-N 1-[3-(4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)propyl]pyrrolidin-2-one Chemical compound C1=C2C=3N(CCCN4C(CCC4)=O)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 DDKUAZFTMXXZIS-UHFFFAOYSA-N 0.000 claims 1
- CSUABWIZBRPWDY-UHFFFAOYSA-N 1-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C(C=C1F)=CC=C1N1CCN(C)CC1 CSUABWIZBRPWDY-UHFFFAOYSA-N 0.000 claims 1
- AOQTWHZWOJXHCJ-UHFFFAOYSA-N 1-[4-(4-fluorophenoxy)phenyl]-8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=C(F)C=C1 AOQTWHZWOJXHCJ-UHFFFAOYSA-N 0.000 claims 1
- WIFTXZARFQYDOI-UHFFFAOYSA-N 1-benzyl-4-methyl-6-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC=C2C=3N(CC=4C=CC=CC=4)CCC=3C(C)=NC2=C1OC1=CC=CC=C1 WIFTXZARFQYDOI-UHFFFAOYSA-N 0.000 claims 1
- TUDGJSQTQPFGPB-UHFFFAOYSA-N 1-benzyl-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CC=4C=CC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 TUDGJSQTQPFGPB-UHFFFAOYSA-N 0.000 claims 1
- IGTRPTSSKHKRGR-UHFFFAOYSA-N 1-benzyl-6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1CC1=CC=CC=C1 IGTRPTSSKHKRGR-UHFFFAOYSA-N 0.000 claims 1
- QNZGQQRIFLNEAF-UHFFFAOYSA-N 1-cyclohexyl-4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C4CCCCC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 QNZGQQRIFLNEAF-UHFFFAOYSA-N 0.000 claims 1
- INLASFAPRUISQI-UHFFFAOYSA-N 1-cyclohexyl-8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C1CCCCC1 INLASFAPRUISQI-UHFFFAOYSA-N 0.000 claims 1
- UMNUCTVIDKJPPV-UHFFFAOYSA-N 1-cyclopropyl-6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1CC1 UMNUCTVIDKJPPV-UHFFFAOYSA-N 0.000 claims 1
- GVEZIHKRYBHEFX-MNOVXSKESA-N 13C-Cerulenin Natural products CC=CCC=CCCC(=O)[C@H]1O[C@@H]1C(N)=O GVEZIHKRYBHEFX-MNOVXSKESA-N 0.000 claims 1
- CTMXMUYXFHJAGX-UHFFFAOYSA-N 2,4-dimethyl-1-(2-methylphenyl)-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound CC1=NC=2C=CC(=CC=2C2=C1CC(N2C1=C(C=CC=C1)C)C)OC1=CC=CC=C1 CTMXMUYXFHJAGX-UHFFFAOYSA-N 0.000 claims 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims 1
- CUICHUOHGNCCEZ-UHFFFAOYSA-N 2-[4-(8-methoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)phenoxy]-n,n-dimethylethanamine Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C1=CC=C(OCCN(C)C)C=C1 CUICHUOHGNCCEZ-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 claims 1
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 1
- ZZRIVGZAWYEOIT-UHFFFAOYSA-N 3-(6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)-5-methylphenol Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1=CC(C)=CC(O)=C1 ZZRIVGZAWYEOIT-UHFFFAOYSA-N 0.000 claims 1
- MBBZEMJDPTXWPF-UHFFFAOYSA-N 3-(6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)phenol Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1=CC=CC(O)=C1 MBBZEMJDPTXWPF-UHFFFAOYSA-N 0.000 claims 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 claims 1
- NKSVVROSSLQQJO-UHFFFAOYSA-N 4,6-dimethyl-1-(2-methylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound CC1=CC=CC=C1N1C(C=2C(=C(C)C=CC=2)N=C2C)=C2CC1 NKSVVROSSLQQJO-UHFFFAOYSA-N 0.000 claims 1
- QEDRWALBLFELLY-UHFFFAOYSA-N 4,6-dimethyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=C(C)C=CC=C3C=2N1CCC1=CC=CC=C1 QEDRWALBLFELLY-UHFFFAOYSA-N 0.000 claims 1
- LBSOBFKAGJBZKF-UHFFFAOYSA-N 4,6-dimethyl-1-(4-methylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(C)=CC=C1N1C(C=2C(=C(C)C=CC=2)N=C2C)=C2CC1 LBSOBFKAGJBZKF-UHFFFAOYSA-N 0.000 claims 1
- NPQZNMPPUASIAY-UHFFFAOYSA-N 4-(6,8-dimethoxy-4-methyl-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)phenol Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1=CC=C(O)C=C1 NPQZNMPPUASIAY-UHFFFAOYSA-N 0.000 claims 1
- HIWXQEJLPWTZFO-UHFFFAOYSA-N 4-(6,8-dimethoxy-4-methylpyrrolo[3,2-c]quinolin-1-yl)phenol Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2C=CN1C1=CC=C(O)C=C1 HIWXQEJLPWTZFO-UHFFFAOYSA-N 0.000 claims 1
- IIVINQSXIFCKDQ-UHFFFAOYSA-N 4-[4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinolin-8-yl]morpholine Chemical compound C1CC=2C(C)=NC3=CC=C(N4CCOCC4)C=C3C=2N1C(C=C1)=CC=C1OC1=CC=CC=C1 IIVINQSXIFCKDQ-UHFFFAOYSA-N 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- LSLSJCBCSMDBDF-UHFFFAOYSA-N 4-methyl-1-(1-methylpiperidin-4-yl)-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CN(C)CCC1N1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 LSLSJCBCSMDBDF-UHFFFAOYSA-N 0.000 claims 1
- GHFIQLAXTNNRLV-UHFFFAOYSA-N 4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinolin-8-ol Chemical compound C1CC=2C(C)=NC3=CC=C(O)C=C3C=2N1CCC1=CC=CC=C1 GHFIQLAXTNNRLV-UHFFFAOYSA-N 0.000 claims 1
- QUFQHMUQFIYGPT-UHFFFAOYSA-N 4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=CC=C3C=2N1CCC1=CC=CC=C1 QUFQHMUQFIYGPT-UHFFFAOYSA-N 0.000 claims 1
- JHISNRHQKKRLOW-UHFFFAOYSA-N 4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline-8-carbonitrile Chemical compound C1CC=2C(C)=NC3=CC=C(C#N)C=C3C=2N1CCC1=CC=CC=C1 JHISNRHQKKRLOW-UHFFFAOYSA-N 0.000 claims 1
- CPJSSAJHALVERW-UHFFFAOYSA-N 4-methyl-1-(2-phenylethyl)-8-(trifluoromethoxy)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=C(OC(F)(F)F)C=C3C=2N1CCC1=CC=CC=C1 CPJSSAJHALVERW-UHFFFAOYSA-N 0.000 claims 1
- HNLIUBRFDKQBSQ-UHFFFAOYSA-N 4-methyl-1-(3-phenoxyphenyl)-8-piperidin-1-yl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=C(N4CCCCC4)C=C3C=2N1C(C=1)=CC=CC=1OC1=CC=CC=C1 HNLIUBRFDKQBSQ-UHFFFAOYSA-N 0.000 claims 1
- PFJCDXIDNLOOHH-UHFFFAOYSA-N 4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=CC=C3C=2N1C(C=C1)=CC=C1OC1=CC=CC=C1 PFJCDXIDNLOOHH-UHFFFAOYSA-N 0.000 claims 1
- WFTPBIYULRUZRI-UHFFFAOYSA-N 4-methyl-1-(4-phenoxyphenyl)-8-(trifluoromethoxy)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=C(OC(F)(F)F)C=C3C=2N1C(C=C1)=CC=C1OC1=CC=CC=C1 WFTPBIYULRUZRI-UHFFFAOYSA-N 0.000 claims 1
- OCNQGRNHEJVECX-UHFFFAOYSA-N 4-methyl-1-[(5-methylpyrazin-2-yl)methyl]-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=NC(C)=CN=C1CN1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 OCNQGRNHEJVECX-UHFFFAOYSA-N 0.000 claims 1
- GUNJEAPVKBNUMO-UHFFFAOYSA-N 4-methyl-6-phenoxy-1-(4-propan-2-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(C(C)C)=CC=C1N1C(C=2C(=C(OC=3C=CC=CC=3)C=CC=2)N=C2C)=C2CC1 GUNJEAPVKBNUMO-UHFFFAOYSA-N 0.000 claims 1
- ZXKURZKHOIORFH-UHFFFAOYSA-N 4-methyl-6-phenoxy-1-phenyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC=C2C=3N(C=4C=CC=CC=4)CCC=3C(C)=NC2=C1OC1=CC=CC=C1 ZXKURZKHOIORFH-UHFFFAOYSA-N 0.000 claims 1
- QLAYMTWYACQEME-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C4C5=CC=CC=C5CCC4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 QLAYMTWYACQEME-UHFFFAOYSA-N 0.000 claims 1
- MVIIBSQHOHBBAY-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(1-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C=1C=CC=CC=1C(C)N1CCC(C(=NC2=CC=3)C)=C1C2=CC=3OC1=CC=CC=C1 MVIIBSQHOHBBAY-UHFFFAOYSA-N 0.000 claims 1
- CJUOXFXCIZPQNO-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(2-phenylpropyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C=1C=CC=CC=1C(C)CN1CCC(C(=NC2=CC=3)C)=C1C2=CC=3OC1=CC=CC=C1 CJUOXFXCIZPQNO-UHFFFAOYSA-N 0.000 claims 1
- VLESDXNQZBILRD-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(2-pyridin-2-ylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CCC=4N=CC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 VLESDXNQZBILRD-UHFFFAOYSA-N 0.000 claims 1
- RMEIYFJFDBXHEE-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(2-pyridin-3-ylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CCC=4C=NC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 RMEIYFJFDBXHEE-UHFFFAOYSA-N 0.000 claims 1
- SLEVTVFWKZEBCZ-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(4-propan-2-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(C(C)C)=CC=C1N1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 SLEVTVFWKZEBCZ-UHFFFAOYSA-N 0.000 claims 1
- SAFDQBZGFCKGKT-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(4-pyridin-3-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C=4C=CC(=CC=4)C=4C=NC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 SAFDQBZGFCKGKT-UHFFFAOYSA-N 0.000 claims 1
- CADNGSHALBASBD-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-(pyridin-2-ylmethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(CC=4N=CC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 CADNGSHALBASBD-UHFFFAOYSA-N 0.000 claims 1
- KUQZGNDIYTWIKF-UHFFFAOYSA-N 4-methyl-8-phenoxy-1-phenyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=C2C=3N(C=4C=CC=CC=4)CCC=3C(C)=NC2=CC=C1OC1=CC=CC=C1 KUQZGNDIYTWIKF-UHFFFAOYSA-N 0.000 claims 1
- XTCCYICXVNNTBY-UHFFFAOYSA-N 4-methyl-8-piperidin-1-yl-1-(4-piperidin-1-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=C(N4CCCCC4)C=C3C=2N1C(C=C1)=CC=C1N1CCCCC1 XTCCYICXVNNTBY-UHFFFAOYSA-N 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 claims 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- TTWYUKQEYYCWQW-UHFFFAOYSA-N 6,8-dimethoxy-1-(6-methoxypyridin-3-yl)-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1=CC=C(OC)N=C1 TTWYUKQEYYCWQW-UHFFFAOYSA-N 0.000 claims 1
- SQYIFJLZNGUHBH-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(2-phenoxyethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1CCOC1=CC=CC=C1 SQYIFJLZNGUHBH-UHFFFAOYSA-N 0.000 claims 1
- WYHVSNMFKADSOC-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1CCC1=CC=CC=C1 WYHVSNMFKADSOC-UHFFFAOYSA-N 0.000 claims 1
- SHBOCEIIBBVDNZ-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(3-methylbutyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C12=CC(OC)=CC(OC)=C2N=C(C)C2=C1N(CCC(C)C)CC2 SHBOCEIIBBVDNZ-UHFFFAOYSA-N 0.000 claims 1
- GLHHBLOLVYBZPQ-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=CC=C1 GLHHBLOLVYBZPQ-UHFFFAOYSA-N 0.000 claims 1
- UWEQHRXZDVDZJW-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(4-propan-2-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C1=CC=C(C(C)C)C=C1 UWEQHRXZDVDZJW-UHFFFAOYSA-N 0.000 claims 1
- AKENEKQTIPGESW-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(4-pyridin-3-yloxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=CN=C1 AKENEKQTIPGESW-UHFFFAOYSA-N 0.000 claims 1
- HJPDBURZIUQGSH-UHFFFAOYSA-N 6,8-dimethoxy-4-methyl-1-(6-phenoxypyridin-3-yl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC(OC)=C3N=C(C)C=2CCN1C(C=N1)=CC=C1OC1=CC=CC=C1 HJPDBURZIUQGSH-UHFFFAOYSA-N 0.000 claims 1
- YCWQAMGASJSUIP-YFKPBYRVSA-N 6-diazo-5-oxo-L-norleucine Chemical compound OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-] YCWQAMGASJSUIP-YFKPBYRVSA-N 0.000 claims 1
- 229960005538 6-diazo-5-oxo-L-norleucine Drugs 0.000 claims 1
- YXVIISNNLLQHIF-UHFFFAOYSA-N 6-methoxy-4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC2=C(C)N=C3C(OC)=CC=CC3=C2N1C(C=C1)=CC=C1OC1=CC=CC=C1 YXVIISNNLLQHIF-UHFFFAOYSA-N 0.000 claims 1
- VRCXQXCXLBOLQJ-UHFFFAOYSA-N 6-methoxy-4-methyl-1-(4-propan-2-ylphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC2=C(C)N=C3C(OC)=CC=CC3=C2N1C1=CC=C(C(C)C)C=C1 VRCXQXCXLBOLQJ-UHFFFAOYSA-N 0.000 claims 1
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims 1
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims 1
- NPIJLFCVBFZOHV-UHFFFAOYSA-N 8-chloro-4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC=2C(C)=NC3=CC=C(Cl)C=C3C=2N1CCC1=CC=CC=C1 NPIJLFCVBFZOHV-UHFFFAOYSA-N 0.000 claims 1
- OPTGIJHJBUNGEW-UHFFFAOYSA-N 8-ethoxy-4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OCC)=CC=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=CC=C1 OPTGIJHJBUNGEW-UHFFFAOYSA-N 0.000 claims 1
- WKMGLYHWCLEENB-UHFFFAOYSA-N 8-methoxy-1-(4-methoxyphenyl)-4-methyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=CC(OC)=CC=C1N1C(C=2C(=CC=C(OC)C=2)N=C2C)=C2CC1 WKMGLYHWCLEENB-UHFFFAOYSA-N 0.000 claims 1
- AKIQHLINOWGGFA-UHFFFAOYSA-N 8-methoxy-4-methyl-1-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CCC2=CC=CC=C2C1N1CCC2=C1C1=CC(OC)=CC=C1N=C2C AKIQHLINOWGGFA-UHFFFAOYSA-N 0.000 claims 1
- RFDSXTHGGZUSTG-UHFFFAOYSA-N 8-methoxy-4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinolin-6-ol Chemical compound C1=2C3=CC(OC)=CC(O)=C3N=C(C)C=2CCN1CCC1=CC=CC=C1 RFDSXTHGGZUSTG-UHFFFAOYSA-N 0.000 claims 1
- YYMCUFGHQWIGFQ-UHFFFAOYSA-N 8-methoxy-4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1CCC1=CC=CC=C1 YYMCUFGHQWIGFQ-UHFFFAOYSA-N 0.000 claims 1
- OSKYEKWSYSWZRJ-UHFFFAOYSA-N 8-methoxy-4-methyl-1-(4-phenoxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=CC=C1 OSKYEKWSYSWZRJ-UHFFFAOYSA-N 0.000 claims 1
- BRDNRZGCHKVNCT-UHFFFAOYSA-N 8-methoxy-4-methyl-1-(4-pyridin-3-yloxyphenyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C(C=C1)=CC=C1OC1=CC=CN=C1 BRDNRZGCHKVNCT-UHFFFAOYSA-N 0.000 claims 1
- WVOLDYZDIQCLBM-UHFFFAOYSA-N 8-methoxy-4-methyl-1-phenyl-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1=2C3=CC(OC)=CC=C3N=C(C)C=2CCN1C1=CC=CC=C1 WVOLDYZDIQCLBM-UHFFFAOYSA-N 0.000 claims 1
- TUBLQASFQYGWFS-UHFFFAOYSA-N 8-phenoxy-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline Chemical compound C1CC2=CN=C3C=CC(OC=4C=CC=CC=4)=CC3=C2N1CCC1=CC=CC=C1 TUBLQASFQYGWFS-UHFFFAOYSA-N 0.000 claims 1
- HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 claims 1
- YKJYKKNCCRKFSL-UHFFFAOYSA-N Anisomycin Natural products C1=CC(OC)=CC=C1CC1C(OC(C)=O)C(O)CN1 YKJYKKNCCRKFSL-UHFFFAOYSA-N 0.000 claims 1
- UIFFUZWRFRDZJC-UHFFFAOYSA-N Antimycin A1 Natural products CC1OC(=O)C(CCCCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-UHFFFAOYSA-N 0.000 claims 1
- NQWZLRAORXLWDN-UHFFFAOYSA-N Antimycin-A Natural products CCCCCCC(=O)OC1C(C)OC(=O)C(NC(=O)c2ccc(NC=O)cc2O)C(C)OC(=O)C1CCCC NQWZLRAORXLWDN-UHFFFAOYSA-N 0.000 claims 1
- 108010087765 Antipain Proteins 0.000 claims 1
- 108010001478 Bacitracin Proteins 0.000 claims 1
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 claims 1
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 claims 1
- 206010005940 Bone and joint infections Diseases 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- AUJXLBOHYWTPFV-BLWRDSOESA-N CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1 Chemical compound CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1 AUJXLBOHYWTPFV-BLWRDSOESA-N 0.000 claims 1
- 108010020326 Caspofungin Proteins 0.000 claims 1
- 229930186147 Cephalosporin Natural products 0.000 claims 1
- 241000252203 Clupea harengus Species 0.000 claims 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 claims 1
- 229930105110 Cyclosporin A Natural products 0.000 claims 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 1
- 108010036949 Cyclosporine Proteins 0.000 claims 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 claims 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 claims 1
- 108010092160 Dactinomycin Proteins 0.000 claims 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 claims 1
- 108010013198 Daptomycin Proteins 0.000 claims 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims 1
- 108010009858 Echinomycin Proteins 0.000 claims 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- KBHMEHLJSZMEMI-UHFFFAOYSA-N Formycin A Natural products N1N=C2C(N)=NC=NC2=C1C1OC(CO)C(O)C1O KBHMEHLJSZMEMI-UHFFFAOYSA-N 0.000 claims 1
- 108010015899 Glycopeptides Proteins 0.000 claims 1
- 102000002068 Glycopeptides Human genes 0.000 claims 1
- 108010026389 Gramicidin Proteins 0.000 claims 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 201000008327 Haverhill fever Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims 1
- 108010028921 Lipopeptides Proteins 0.000 claims 1
- 108090000988 Lysostaphin Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229930191564 Monensin Natural products 0.000 claims 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 claims 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 claims 1
- ZQLBCAUKNYXILZ-UGKGYDQZSA-N Piericidin A Natural products COc1nc(CC=C(/C)C=CCC(=C[C@H](C)[C@@H](O)C(=CC)C)C)c(C)c(O)c1OC ZQLBCAUKNYXILZ-UGKGYDQZSA-N 0.000 claims 1
- 108010040201 Polymyxins Proteins 0.000 claims 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 claims 1
- 239000004189 Salinomycin Substances 0.000 claims 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 claims 1
- 206010042175 Streptobacillary fever Diseases 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims 1
- YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 108010067973 Valinomycin Proteins 0.000 claims 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 claims 1
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 claims 1
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 claims 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229930183665 actinomycin Natural products 0.000 claims 1
- XJLATMLVMSFZBN-VYDXJSESSA-N actinonin Chemical compound CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO XJLATMLVMSFZBN-VYDXJSESSA-N 0.000 claims 1
- XJLATMLVMSFZBN-UHFFFAOYSA-N actinonine Natural products CCCCCC(CC(=O)NO)C(=O)NC(C(C)C)C(=O)N1CCCC1CO XJLATMLVMSFZBN-UHFFFAOYSA-N 0.000 claims 1
- BHAYDBSYOBONRV-IUYQGCFVSA-N alafosfalin Chemical compound C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O BHAYDBSYOBONRV-IUYQGCFVSA-N 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- UIFFUZWRFRDZJC-SBOOETFBSA-N antimycin A Chemical compound C[C@H]1OC(=O)[C@H](CCCCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@H]1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-SBOOETFBSA-N 0.000 claims 1
- PVEVXUMVNWSNIG-UHFFFAOYSA-N antimycin A3 Natural products CC1OC(=O)C(CCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O PVEVXUMVNWSNIG-UHFFFAOYSA-N 0.000 claims 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 claims 1
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 claims 1
- 229950006334 apramycin Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229960002756 azacitidine Drugs 0.000 claims 1
- 229950011321 azaserine Drugs 0.000 claims 1
- 229960004099 azithromycin Drugs 0.000 claims 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims 1
- 229960003644 aztreonam Drugs 0.000 claims 1
- 229960003071 bacitracin Drugs 0.000 claims 1
- 229930184125 bacitracin Natural products 0.000 claims 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims 1
- 239000003899 bactericide agent Substances 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003781 beta lactamase inhibitor Substances 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 claims 1
- 201000000053 blastoma Diseases 0.000 claims 1
- GVEZIHKRYBHEFX-UHFFFAOYSA-N caerulein A Natural products CC=CCC=CCCC(=O)C1OC1C(N)=O GVEZIHKRYBHEFX-UHFFFAOYSA-N 0.000 claims 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims 1
- 229960003034 caspofungin Drugs 0.000 claims 1
- JYIKNQVWKBUSNH-WVDDFWQHSA-N caspofungin Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@H](O)CCN)=CC=C(O)C=C1 JYIKNQVWKBUSNH-WVDDFWQHSA-N 0.000 claims 1
- 229940124587 cephalosporin Drugs 0.000 claims 1
- 150000001780 cephalosporins Chemical class 0.000 claims 1
- GVEZIHKRYBHEFX-NQQPLRFYSA-N cerulenin Chemical compound C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O GVEZIHKRYBHEFX-NQQPLRFYSA-N 0.000 claims 1
- 229950005984 cerulenin Drugs 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 229960001265 ciclosporin Drugs 0.000 claims 1
- 229960002227 clindamycin Drugs 0.000 claims 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims 1
- 229960002291 clindamycin phosphate Drugs 0.000 claims 1
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 claims 1
- 229960004287 clofazimine Drugs 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 claims 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 claims 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 claims 1
- 229930182483 coumarin glycoside Natural products 0.000 claims 1
- 150000008140 coumarin glycosides Chemical class 0.000 claims 1
- WTIJXIZOODAMJT-DHFGXMAYSA-N coumermycin A1 Chemical compound O([C@@H]1[C@H](C(O[C@@H](OC=2C(=C3OC(=O)C(NC(=O)C=4C(=C(C(=O)NC=5C(OC6=C(C)C(O[C@H]7[C@@H]([C@H](OC(=O)C=8NC(C)=CC=8)[C@@H](OC)C(C)(C)O7)O)=CC=C6C=5O)=O)NC=4)C)=C(O)C3=CC=2)C)[C@@H]1O)(C)C)OC)C(=O)C1=CC=C(C)N1 WTIJXIZOODAMJT-DHFGXMAYSA-N 0.000 claims 1
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- JVHIPYJQMFNCEK-UHFFFAOYSA-N cytochalasin Natural products N1C(=O)C2(C(C=CC(C)CC(C)CC=C3)OC(C)=O)C3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 JVHIPYJQMFNCEK-UHFFFAOYSA-N 0.000 claims 1
- ZMAODHOXRBLOQO-UHFFFAOYSA-N cytochalasin-A Natural products N1C(=O)C23OC(=O)C=CC(=O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 ZMAODHOXRBLOQO-UHFFFAOYSA-N 0.000 claims 1
- 229960000860 dapsone Drugs 0.000 claims 1
- 229960005484 daptomycin Drugs 0.000 claims 1
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 201000008184 embryoma Diseases 0.000 claims 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 claims 1
- 229960002694 emetine Drugs 0.000 claims 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 claims 1
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- 229960000285 ethambutol Drugs 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 229960004413 flucytosine Drugs 0.000 claims 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- KBHMEHLJSZMEMI-KSYZLYKTSA-N formycin A Chemical compound N=1NC=2C(N)=NC=NC=2C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O KBHMEHLJSZMEMI-KSYZLYKTSA-N 0.000 claims 1
- 229960002442 glucosamine Drugs 0.000 claims 1
- 229960004905 gramicidin Drugs 0.000 claims 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 claims 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims 1
- 229960002867 griseofulvin Drugs 0.000 claims 1
- 235000019514 herring Nutrition 0.000 claims 1
- 239000004312 hexamethylene tetramine Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 claims 1
- 125000004130 indan-2-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])(*)C2([H])[H] 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000011147 inorganic material Substances 0.000 claims 1
- PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 claims 1
- PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 claims 1
- 229960003350 isoniazid Drugs 0.000 claims 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003835 ketolide antibiotic agent Substances 0.000 claims 1
- 210000000244 kidney pelvis Anatomy 0.000 claims 1
- 239000010985 leather Substances 0.000 claims 1
- 229960003376 levofloxacin Drugs 0.000 claims 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 claims 1
- 229960003907 linezolid Drugs 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- BYZQOIIBUBDGTJ-UHFFFAOYSA-N methyl 4-methyl-1-(2-phenylethyl)-2,3-dihydropyrrolo[3,2-c]quinoline-8-carboxylate Chemical compound C1=2C3=CC(C(=O)OC)=CC=C3N=C(C)C=2CCN1CCC1=CC=CC=C1 BYZQOIIBUBDGTJ-UHFFFAOYSA-N 0.000 claims 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims 1
- 229960005358 monensin Drugs 0.000 claims 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 claims 1
- 125000005322 morpholin-1-yl group Chemical group 0.000 claims 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 claims 1
- 229960003702 moxifloxacin Drugs 0.000 claims 1
- FGBZENWPUHURRD-UHFFFAOYSA-N n,n-dimethyl-2-[4-(4-methyl-8-phenoxy-2,3-dihydropyrrolo[3,2-c]quinolin-1-yl)phenoxy]ethanamine Chemical compound C1=CC(OCCN(C)C)=CC=C1N1C(C=2C(=CC=C(OC=3C=CC=CC=3)C=2)N=C2C)=C2CC1 FGBZENWPUHURRD-UHFFFAOYSA-N 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 claims 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 claims 1
- 229960001907 nitrofurazone Drugs 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 239000011368 organic material Substances 0.000 claims 1
- 239000003973 paint Substances 0.000 claims 1
- 210000002741 palatine tonsil Anatomy 0.000 claims 1
- 239000000123 paper Substances 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- BBLGCDSLCDDALX-LKGBESRRSA-N piericidin A Chemical compound COC=1NC(C\C=C(/C)C\C=C\C(\C)=C\[C@@H](C)[C@@H](O)C(\C)=C\C)=C(C)C(=O)C=1OC BBLGCDSLCDDALX-LKGBESRRSA-N 0.000 claims 1
- 150000004291 polyenes Chemical class 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 229950010131 puromycin Drugs 0.000 claims 1
- 229960005206 pyrazinamide Drugs 0.000 claims 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims 1
- AUJXLBOHYWTPFV-UHFFFAOYSA-N quinomycin A Natural products CN1C(=O)C(C)NC(=O)C(NC(=O)C=2N=C3C=CC=CC3=NC=2)COC(=O)C(C(C)C)N(C)C(=O)C2N(C)C(=O)C(C)NC(=O)C(NC(=O)C=3N=C4C=CC=CC4=NC=3)COC(=O)C(C(C)C)N(C)C(=O)C1CSC2SC AUJXLBOHYWTPFV-UHFFFAOYSA-N 0.000 claims 1
- 208000010563 rat-bite fever Diseases 0.000 claims 1
- 229960000885 rifabutin Drugs 0.000 claims 1
- 229960001225 rifampicin Drugs 0.000 claims 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims 1
- 229960001548 salinomycin Drugs 0.000 claims 1
- 235000019378 salinomycin Nutrition 0.000 claims 1
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 claims 1
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 208000017810 streptobacillary rat-bite fever Diseases 0.000 claims 1
- 229940041030 streptogramins Drugs 0.000 claims 1
- 229960005322 streptomycin Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- HDZZVAMISRMYHH-LITAXDCLSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O HDZZVAMISRMYHH-LITAXDCLSA-N 0.000 claims 1
- ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 claims 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 claims 1
- 229950009811 ubenimex Drugs 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010014979 Epidemic typhus Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000257176 Hypoderma <fly> Species 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010050346 Oropharyngeal candidiasis Diseases 0.000 description 1
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 241000287531 Psittacidae Species 0.000 description 1
- 208000021326 Ritter disease Diseases 0.000 description 1
- 206010041736 Sporotrichosis Diseases 0.000 description 1
- 208000031726 Spotted Fever Group Rickettsiosis Diseases 0.000 description 1
- 206010041929 Staphylococcal scalded skin syndrome Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000009788 Urogenital Tuberculosis Diseases 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 206010033072 otitis externa Diseases 0.000 description 1
- 206010039766 scrub typhus Diseases 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000003196 skeletal tuberculosis Diseases 0.000 description 1
- 201000004284 spotted fever Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0522715.2A GB0522715D0 (en) | 2005-11-08 | 2005-11-08 | New use |
| GB0522715.2 | 2005-11-08 | ||
| PCT/GB2006/004178 WO2007054693A1 (en) | 2005-11-08 | 2006-11-08 | Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009514936A JP2009514936A (ja) | 2009-04-09 |
| JP2009514936A5 true JP2009514936A5 (https=) | 2013-03-07 |
| JP5542336B2 JP5542336B2 (ja) | 2014-07-09 |
Family
ID=35516508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008539493A Active JP5542336B2 (ja) | 2005-11-08 | 2006-11-08 | 臨床的に潜伏性の微生物を死滅させるピロロキノリン化合物の使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8207187B2 (https=) |
| EP (1) | EP1945211B1 (https=) |
| JP (1) | JP5542336B2 (https=) |
| KR (1) | KR101148049B1 (https=) |
| CN (1) | CN101351203B (https=) |
| AU (1) | AU2006313590C1 (https=) |
| BR (1) | BRPI0618374A2 (https=) |
| CA (1) | CA2628729C (https=) |
| DK (1) | DK1945211T3 (https=) |
| ES (1) | ES2558685T3 (https=) |
| GB (1) | GB0522715D0 (https=) |
| HR (1) | HRP20160043T1 (https=) |
| HU (1) | HUE026568T2 (https=) |
| IL (1) | IL191260A (https=) |
| NZ (1) | NZ568035A (https=) |
| PL (1) | PL1945211T3 (https=) |
| PT (1) | PT1945211E (https=) |
| RU (1) | RU2404982C2 (https=) |
| SI (1) | SI1945211T1 (https=) |
| WO (1) | WO2007054693A1 (https=) |
| ZA (1) | ZA200804454B (https=) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0522715D0 (en) | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
| ES2637999T3 (es) * | 2007-05-17 | 2017-10-18 | Helperby Therapeutics Limited | Uso de compuestos de 4-(pirrolidin-1-il)quinolina para eliminar microorganismos clínicamente latentes |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| JP5711135B2 (ja) | 2008-10-24 | 2015-04-30 | センプラ ファーマシューティカルズ，インコーポレイテッド | 胃腸疾患を治療するための方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| RU2457208C2 (ru) * | 2009-07-06 | 2012-07-27 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "ПГФА Росздрава") | 1H-ПИРРОЛО[3,4-b]ХИНОЛИН-3,9(2H,4H)-ДИОНЫ, ОБЛАДАЮЩИЕ ПРОТИВОТУБЕРКУЛЕЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ |
| ES2703253T3 (es) * | 2010-03-30 | 2019-03-07 | Helperby Therapeutics Ltd | Nueva combinación y uso |
| GB201013207D0 (en) | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
| WO2012017215A1 (en) | 2010-08-05 | 2012-02-09 | Helperby Therapeutics Limited | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| US20130245060A1 (en) * | 2010-10-08 | 2013-09-19 | Helperby Therapeutics Limited | Novel composition |
| KR101254038B1 (ko) * | 2011-01-12 | 2013-04-12 | 한국화학연구원 | 퀴놀린올 화합물을 유효성분으로 포함하는 항진균 조성물 |
| GB201107755D0 (en) | 2011-05-10 | 2011-06-22 | Helperby Therapeutics Ltd | Novel compounds |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| AU2014239959A1 (en) | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
| CN105531272B (zh) * | 2013-07-25 | 2017-12-22 | 雅盖隆大学 | 作为5‑ht6拮抗剂的吡咯并喹啉衍生物、其制备方法和用途 |
| US20170119793A1 (en) * | 2014-06-12 | 2017-05-04 | Cem-102 Pharmaceuticals, Inc. | Compositions and methods for treating bone and joint infections |
| GB201416351D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
| HK1250679A1 (zh) | 2015-04-11 | 2019-01-11 | Helperby Therapeutics Limited | 口腔用组合物 |
| WO2016179231A1 (en) * | 2015-05-04 | 2016-11-10 | Board Of Trustees Of Michigan State University | Compositions and methods for inhibiting bacterial growth |
| GB201518969D0 (en) | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
| CN108660189B (zh) * | 2018-05-30 | 2021-09-07 | 杭州千基生物科技有限公司 | 一种用于尿路感染病原体的量子点核酸检测的试剂盒 |
| CN109503569B (zh) * | 2019-01-03 | 2021-01-15 | 山东大学 | 噻唑类衍生物及其制备方法和应用 |
| US11896612B2 (en) | 2019-03-29 | 2024-02-13 | Board Of Trustees Of Michigan State University | Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles |
| CN111297852B (zh) * | 2019-12-05 | 2022-03-29 | 宁波大学 | 一种促进三疣梭子蟹雌蟹卵黄积累与卵巢发育的方法 |
| WO2021150613A1 (en) | 2020-01-20 | 2021-07-29 | Incyte Corporation | Spiro compounds as inhibitors of kras |
| US11739102B2 (en) | 2020-05-13 | 2023-08-29 | Incyte Corporation | Fused pyrimidine compounds as KRAS inhibitors |
| GB202012797D0 (en) | 2020-08-17 | 2020-09-30 | Helperby Therapeautics Ltd | Disinfectant composition |
| US11999752B2 (en) | 2020-08-28 | 2024-06-04 | Incyte Corporation | Vinyl imidazole compounds as inhibitors of KRAS |
| US11767320B2 (en) | 2020-10-02 | 2023-09-26 | Incyte Corporation | Bicyclic dione compounds as inhibitors of KRAS |
| WO2022204112A1 (en) | 2021-03-22 | 2022-09-29 | Incyte Corporation | Imidazole and triazole kras inhibitors |
| MX2024000357A (es) | 2021-07-07 | 2024-02-12 | Incyte Corp | Compuestos triciclicos como inhibidores de homologo de oncogen viral de sarcoma de rata kirsten (kras). |
| WO2023287896A1 (en) | 2021-07-14 | 2023-01-19 | Incyte Corporation | Tricyclic compounds as inhibitors of kras |
| US12441742B2 (en) | 2021-08-31 | 2025-10-14 | Incyte Corporation | Naphthyridine compounds as inhibitors of KRAS |
| WO2023049697A1 (en) | 2021-09-21 | 2023-03-30 | Incyte Corporation | Hetero-tricyclic compounds as inhibitors of kras |
| CA3234375A1 (en) | 2021-10-01 | 2023-04-06 | Incyte Corporation | Pyrazoloquinoline kras inhibitors |
| CA3235146A1 (en) | 2021-10-14 | 2023-04-20 | Incyte Corporation | Quinoline compounds as inhibitors of kras |
| US11926627B1 (en) | 2023-08-30 | 2024-03-12 | King Faisal University | Substituted 7-methyl quinoline derivatives as antitubercular agents |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US725745A (en) * | 1902-07-09 | 1903-04-21 | Edwin A Moore | Coke-oven door. |
| DE831249C (de) * | 1948-02-09 | 1952-02-11 | Ciba A G | Verfahren zur Herstellung heterocyclisch substituierter Diaminochinazoline |
| GB725745A (en) | 1952-05-26 | 1955-03-09 | Bayer Ag | Pyrrolinoquinolines and processes for making same |
| US2691023A (en) * | 1952-05-26 | 1954-10-05 | Schenley Ind Inc | Dihydropyrrolo-(3.2-c) quinoline derivatives |
| US2714593A (en) * | 1952-05-26 | 1955-08-02 | Schenley Ind Inc | Dihydropyrrolo-(3.2-c) quinoline derivatives |
| US2691024A (en) * | 1952-05-26 | 1954-10-05 | Schenley Ind Inc | Dihydropyrrolo-(3.2-c) quinoline derivatives |
| SU726097A1 (ru) * | 1977-10-10 | 1980-04-05 | Донецкий государственный университет | Гетероциклические производные пирролохинолина как стабилизаторы полимерных материалов |
| EP0226508A1 (fr) | 1985-12-02 | 1987-06-24 | Sanofi | Dérivés de l'indolo(3,2-c)quinoléine, leur procédé de préparation et leur activité antitumorale |
| US4771052A (en) * | 1987-02-05 | 1988-09-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines and their use as hypotensive agents |
| GB8717644D0 (en) * | 1987-07-24 | 1987-09-03 | Smithkline Beckman Intercredit | Compounds |
| US5190951A (en) | 1990-10-19 | 1993-03-02 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
| JPH062963A (ja) | 1992-06-23 | 1994-01-11 | Mitsubishi Heavy Ind Ltd | 空気調和機 |
| JP2997828B2 (ja) | 1992-07-30 | 2000-01-11 | 株式会社大塚製薬工場 | キノリン及びナフチリジン誘導体 |
| FR2695126B1 (fr) | 1992-08-27 | 1994-11-10 | Sanofi Elf | Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant. |
| TW593317B (en) * | 1993-06-21 | 2004-06-21 | Janssen Pharmaceutica Nv | Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives |
| US5578315A (en) * | 1993-12-01 | 1996-11-26 | Rutgers, The State University Of New Jersey | Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
| KR100187475B1 (ko) | 1996-05-17 | 1999-05-01 | 이서봉 | 1-아릴-4-옥소 피롤로(3,2-c)퀴놀린 유도체의 제조방법 |
| GB2316072B (en) | 1996-08-05 | 2000-05-10 | Pharmacia Spa | Pyrrolo[3,2-c]quinoline derivatives |
| KR100251522B1 (ko) * | 1997-08-13 | 2000-08-01 | 김충섭 | 할로알콕시기를 함유하는 피롤[3,2-c]퀴놀린 유도체 및 약학적으로 허용되는 그의 염 |
| US6180640B1 (en) * | 1998-06-25 | 2001-01-30 | Sepracor, Inc. | Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto |
| WO2000001696A1 (en) | 1998-07-02 | 2000-01-13 | Korea Research Institute Of Chemical Technology | 3-ALKYLPYRROLO[3,2-c]QUINOLINE DERIVATIVES |
| AU1061100A (en) | 1998-11-09 | 2000-05-29 | St. George's Enterprises Limited | Screening process for antibacterial agents |
| JP4100865B2 (ja) * | 1999-12-13 | 2008-06-11 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 三環式縮合異項環化合物、その製造法およびその医薬 |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| EP1560584B1 (en) * | 2001-04-06 | 2009-01-14 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
| US7074801B1 (en) * | 2001-04-26 | 2006-07-11 | Eisai Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| BR0312204A (pt) | 2002-06-27 | 2005-04-26 | Schering Ag | Antagonista de receptor ccr5 de quinolina substituìda |
| CL2004000409A1 (es) | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| US7875604B2 (en) | 2004-02-04 | 2011-01-25 | University Of Virginia Patent Foundation | Compounds that inhibit HIV particle formation |
| KR20070015598A (ko) | 2004-04-28 | 2007-02-05 | 다케다 야쿠힌 고교 가부시키가이샤 | 융합 퀴놀린 유도체 및 이의 용도 |
| US20060074105A1 (en) | 2004-09-20 | 2006-04-06 | Serenex, Inc. | Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| US20060183763A1 (en) | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
| GB0522715D0 (en) * | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| WO2012017215A1 (en) * | 2010-08-05 | 2012-02-09 | Helperby Therapeutics Limited | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
-
2005
- 2005-11-08 GB GBGB0522715.2A patent/GB0522715D0/en not_active Ceased
-
2006
- 2006-11-08 HR HRP20160043TT patent/HRP20160043T1/hr unknown
- 2006-11-08 SI SI200632016T patent/SI1945211T1/sl unknown
- 2006-11-08 RU RU2008122912/04A patent/RU2404982C2/ru not_active IP Right Cessation
- 2006-11-08 JP JP2008539493A patent/JP5542336B2/ja active Active
- 2006-11-08 PL PL06808472T patent/PL1945211T3/pl unknown
- 2006-11-08 EP EP06808472.2A patent/EP1945211B1/en active Active
- 2006-11-08 WO PCT/GB2006/004178 patent/WO2007054693A1/en not_active Ceased
- 2006-11-08 PT PT68084722T patent/PT1945211E/pt unknown
- 2006-11-08 US US12/092,947 patent/US8207187B2/en active Active
- 2006-11-08 DK DK06808472.2T patent/DK1945211T3/en active
- 2006-11-08 NZ NZ568035A patent/NZ568035A/en not_active IP Right Cessation
- 2006-11-08 CA CA2628729A patent/CA2628729C/en active Active
- 2006-11-08 HU HUE06808472A patent/HUE026568T2/hu unknown
- 2006-11-08 ES ES06808472.2T patent/ES2558685T3/es active Active
- 2006-11-08 CN CN2006800500487A patent/CN101351203B/zh active Active
- 2006-11-08 KR KR1020087013544A patent/KR101148049B1/ko not_active Expired - Fee Related
- 2006-11-08 BR BRPI0618374-3A patent/BRPI0618374A2/pt active Search and Examination
- 2006-11-08 AU AU2006313590A patent/AU2006313590C1/en not_active Ceased
-
2008
- 2008-05-05 IL IL191260A patent/IL191260A/en not_active IP Right Cessation
- 2008-05-22 ZA ZA200804454A patent/ZA200804454B/xx unknown
-
2012
- 2012-05-17 US US13/473,707 patent/US9694006B2/en active Active
-
2017
- 2017-05-30 US US15/608,032 patent/US10493071B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009514936A5 (https=) | ||
| HRP20160043T1 (hr) | Uporaba spojeva pirolokinolina za suzbijanje kliniäśki latentnih mikroorganizama | |
| JP2010527346A5 (https=) | ||
| RU2009146828A (ru) | Применение соединений 4-(пирролидин-1-ил)хинолинадля уничтожения клинически латентных микроорганизмов | |
| WO2008117079B1 (en) | Antimicrobial compounds based upon 4-aminoquinoline | |
| JP6265395B2 (ja) | ピロロキノリン化合物と、β−ラクタム系抗微生物剤、ムピロシンまたはクロルヘキシジンとを組み合わせてなる、細菌感染の予防および／または治療薬 | |
| JP5932762B2 (ja) | 微生物感染に対する治療薬 | |
| Huang et al. | Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens | |
| JP5902188B2 (ja) | 薬学的組成物 | |
| JP2013532717A (ja) | ピロロキノリン化合物およびアミノグリコシド系抗微生物剤の組み合わせ | |
| JP2013542226A5 (https=) | ||
| WO2018162928A1 (en) | Method for restoring efficacy of an antibacterial agent | |
| HK1140146A (en) | Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |